Download PDF
Drug Res (Stuttg)
DOI: 10.1055/a-0692-2171
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Correction: In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic Rats

Bijan Ghorbanpour Oskouei
1   Food and Drug Affairs, Tabriz University of Medical Science, Tabriz, Iran
2   Student Research Committee, Tabriz University of Medical Science, Tabriz, Iran
,
Soheil Abbaspour-Ravasjani
3   Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
,
Seyed Jamal Musavinejad
4   Islamic Azad University, Tabriz Branch, Faculty of Veterinary Medicine, Tabriz, Iran
,
Seyed Ahmad Salehzadeh
5   Department of Medicinal Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
,
Alireza Abdolhosseinzadeh
6   Young Researchers and Elite Club, Bonab Branch, Islamic Azad university, Bonab, Iran
,
Hamed Hamishehkar
7   Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
,
Kazem Ghahremanzadeh
8   Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran
,
Behrooz Shokouhi
8   Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran
› Author Affiliations
Further Information

Publication History

Publication Date:
24 August 2018 (online)

Also available at
    Permissions and Reprints

Correction to:

In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic RatsDrug Res (Stuttg) 2019; 69(01): 46-52
DOI: 10.1055/a-0646-3803

Erratum

In vivo Evaluation of Anti-Hyperglycemic, Anti-hyperlipidemic and Anti-Oxidant Status of Liver and Kidney of Thymol in STZ-Induced Diabetic Rats

Bijan Ghorbanpour Oskouei, Soheil Abbaspour-Ravasjani, Seyed Jamal Musavinejad et al.

Drug Res 2018, DOI: 10.1055/a-0646-3803

The institute affiliations of Soheil Abbaspour-Ravasjani and Hamed Hamishehkar has been corrected.